1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Zydus Lifesciences Ltd. Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Founded in 1952, Zydus Lifesciences (formerly Cadila Healthcare) is a global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of healthcare therapies. Its portfolio includes generics, branded generics, biosim...

Read More
993.45 -1.00 (-0.10%)
1.6M
NSE+BSE Volume

NSE 10 Oct, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert
Regulatory Approval
Zyuds Life gets Health Canada approval for Liothyronine tablets with a market size of CAD 10.9 mn See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
60.0 / 100
Valuation Score
Mid Valuation
42.5 / 100
Momentum Score
Technically Neutral
50.0 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
1,018
1Yr Price target upside is 2%
30 analysts

17

S

3

W

1

O

4

T

SWOT Analysis

Zydus Lifesciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Cadila Healthcare Ltd. worth buying?
860 Votes:
Buy 81.86%
Sell 9.88%
Hold 8.26%
BUY
SELL
HOLD